Mother's Day BiotechDueDiligence Reading List

Be sure to bookmark this link for reading AFTER you've called your mom or completed other Mother's Day festivities with your family! Best wishes to all the moms out there in the BiotechDueDiligence family.

FLINT, NASH, And Biotech: How Big Things Happen
Tom Hughes, CEO of soon-to-IPO Zafgen (LifeSciVC blog) $ICPT

Crowdsourcing medical decisions: Ethicists worry Josh Hardy case may set bad precedent
Ariana Eunjung Cha (Washington Post) $CMRX

How to Read a Scientific Journal Article
American Association for Cancer Research (AACR)

The Feuerstein-Ratain Rule Update: Still Perfect Predicting Small-Cap Cancer Drug Failure
Adam Feuerstein (TheStreet) $OGXI

ASCO Proposes Innovative Patient-Centered Payment System for Cancer Care
American Society for Clinical Oncology weighs in on drug pricing.

Scientific method: Statistical errors
P values, the 'gold standard' of statistical validity, are not as reliable as many scientists assume.
Regina Nuzzo (Nature)

NPS Pharma’s Francois Nader on the Megadeal Fallout for Biotechs
Ben Filder (Xconomy) $NPSP $PFE $AZN

Biotech Due Diligence: Deconstructing the Milestone Calendar
David Sable (Forbes)
Great title, obviously.